Cellular immunity against BK Polyomavirus in kidney transplant recipients: a comprehensive review

Al-Talib, Mohammed, Skaria, Anna and Griffin, Siân 2024. Cellular immunity against BK Polyomavirus in kidney transplant recipients: a comprehensive review. Transplant Infectious Disease 10.1111/tid.14401

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (1MB) | Preview

Abstract

BK polyomavirus (BKPyV) is an important opportunistic viral infection that complicates kidney transplantation. Uncontrolled viral replication may result in BKPyV-associated nephropathy (BKPyVAN), a major cause of premature allograft damage and failure. In the continued absence of proven treatments, management relies on the empirical reduction of immunosuppression to facilitate an effective host immune response to clear the virus. This may be complicated by the risk of allograft rejection. There is compelling evidence that cellular immune responses are key to establishing control after viral reactivation. Measurable peripheral BKPyV-specific T cell responses temporally correlate with declining viral loads and subsequent clearance. Conversely, these responses are delayed or absent in BKPyVAN. How these peripheral findings correspond to the intragraft response, and whether BKPyV-specific T cells contribute to the immunopathology of BKPyVAN, remains poorly understood. Molecular techniques have provided some insights; however, these have been unable to fully discriminate BKPyVAN from cellular rejection to date. Furthermore, the contributions of components of innate cellular immunity, such as natural killer cells, are not known. Herein, we review the role of cellular immunity in BKPyV infection in kidney transplant recipients. We discuss advances in the understanding of how the development, phenotype, and functionality of these responses may determine the balance between viral control and immunopathology, and how this knowledge is being translated into tools to prognosticate and guide individualized immunosuppression reduction. Lastly, we consider how further elucidation of these responses may inform the design of therapies that would revolutionize how BKPyV is managed after transplantation.

Item Type:	Article
Date Type:	Published Online
Status:	In Press
Schools:	Medicine Systems Immunity Research Institute (SIURI)
Publisher:	Wiley
Funders:	Wellcome Trust
Date of First Compliant Deposit:	7 November 2024
Date of Acceptance:	13 October 2024
Last Modified:	25 Nov 2024 16:44
URI:	https://orca.cardiff.ac.uk/id/eprint/173523

Actions (repository staff only)

Edit Item